Management of Splenic Vein Aneurysms
Splenic vein aneurysms should be treated when they reach a size of 2 cm or greater in diameter, especially in pregnant women or those of childbearing age due to the high risk of rupture and associated mortality. 1
Risk Assessment and Indications for Treatment
- Splenic artery aneurysms (SAAs) represent approximately 60% of all visceral artery aneurysms and carry significant risk when ruptured 1
- Treatment is strongly indicated for:
Rupture Risk and Mortality
- Rupture of splenic artery aneurysms is associated with:
- Important caveat: 50% of aneurysms that rupture during pregnancy are smaller than 2 cm, suggesting a lower threshold for intervention may be warranted in this population 1
Treatment Options
Endovascular Treatment (First-line)
- Endovascular intervention is considered first-line treatment for most SAAs due to lower morbidity and mortality compared to surgery 4, 2
- Coil embolization is the most common technique, which can be used alone or with other embolic agents 4
- Stent grafting is another endovascular option for suitable anatomy 2
- Post-embolization syndrome (pain, fever, systemic symptoms) may occur but is usually self-limiting 4
Surgical Treatment
- Reserved primarily for:
- Surgical options include:
Surveillance for Small Aneurysms
- For aneurysms <2 cm in asymptomatic patients without other risk factors:
- Careful monitoring is particularly important in patients with portal hypertension, as they have higher risk of developing SAAs 6
Special Considerations
- Pregnant women with known SAAs require close monitoring and consideration for prophylactic treatment regardless of size 1
- Patients with portal hypertension and splenomegaly have increased risk of developing SAAs and may warrant more aggressive management 6
- The "double rupture phenomenon" occurs in approximately 25% of ruptured cases, with an initial small bleed followed by catastrophic hemorrhage, emphasizing the importance of prompt recognition and treatment 1